LACC Quality of Life Results with Michael Frumovitz
IJGC Podcast - Un pódcast de BMJ Group
In this episode of the IJGC podcast, Dr. Pedro Ramirez interviews Dr. Michael Frumovitz about his recent publication in Lancet Oncology on the quality of life endpoints from the LACC trial. Tune in! You might be very surprised with their results!
